NASDAQ Stock Market
News source@nasdaq.com
Get the latest stock market news, stock information & quotes, data analysis reports, as well as a general overview of the market landscape from Nasdaq.
Following
Followers
Posts
Replies
Highlights
Media
Likes
#Healthcare #AI #Personalization
www.nasdaq.com
Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, positions data and AI as central to building a more personalized, scalable healthcare experience, where every customer interaction strengthens the platform.
#Momentus #AdditiveManufacturing #SpaceTech
www.nasdaq.com
Momentus Stock Surges 58% After Additive-Manufactured Fuel Tank Development Announcement
(RTTNews) - Momentus Inc. (MNTS) shares jumped 57. 67%, trading at $9. 05, up $3. 31, following news that the company has developed an additive-manufactured fuel tank under a strategic collaboration to support future space mission needs.
#HomeDepot #ConstructionTechnology #ContractorTools
www.nasdaq.com
Can Home Depot's New Pro Tools Accelerate Large-Project Wins?
The Home Depot, Inc. HD has been sharpening its focus on complex, high-value professional work by introducing digital tools that reduce the time and friction contractors face when bidding and executing large projects.
#SolarEnergy #RenewableEnergy #CleanTech
www.nasdaq.com
GLW Rides on Strength in Solar Market: A Sign of More Upside?
Corning Incorporated GLW is benefiting from solid market traction in its U. S. -made solar product portfolio. This is driving growth in the company's Hemlock and Emerging Growth Businesses.
#Biotechnology #AutoimmuneDiseases #ClinicalTrials
www.nasdaq.com
Jade Biosciences To Report Phase I Trial Of JADE101 In 1H2026
(RTTNews) - Jade Biosciences, Inc. (JBIO), a clinical-stage biotechnology company developing therapies for autoimmune diseases, announced its 2026 strategic priorities on Monday, including anticipated milestones before the 44th Annual J.
#DominionEnergy #CleanEnergy #Investing
www.nasdaq.com
Dominion Energy Trades Above 200-Day SMA: How to Play the Stock?
Dominion Energy D trading above its 200-day SMA signals a bullish momentum. The company's continued investments in electric and natural gas infrastructure, coupled with a growing focus on renewable energy, underpin its growth outlook.
#HybridAI #ConversationalIntelligence #SpeechRecognition
www.nasdaq.com
How SoundHound's Hybrid AI Model Beats Pure LLM Players
SoundHound AI's SOUN competitive edge lies in its hybrid AI architecture, which blends proprietary deterministic models with large language models (LLMs), rather than relying on LLMs alone.
#WeightManagement #ObesityTreatment #PharmaceuticalInnovation
www.nasdaq.com
Will NVO's Wegovy Pill Approval for Obesity be a Game Changer in 2026?
Last month, Novo Nordisk NVO announced the FDA approval of the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction in the long term, and to reduce the risk of major adverse cardiovascular (CV) events.
#WeightManagement #ObesityTreatment #PharmaceuticalInnovation
www.nasdaq.com
Will NVO's Wegovy Pill Approval for Obesity be a Game Changer in 2026?
Last month, Novo Nordisk NVO announced the FDA approval of the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction in the long term, and to reduce the risk of major adverse cardiovascular (CV) events.
#QuantumComputing #HealthcareInnovation #StrategicPartnerships
www.nasdaq.com
IonQ Expands Strategic Partnerships to Drive Real-World Quantum Use
IonQ IONQ has recently expanded its strategic footprint through a series of high-impact partnerships spanning healthcare, logistics, and academic research, underscoring its ambition to drive real-world adoption of quantum computing.
#QuantumComputing #HealthcareInnovation #StrategicPartnerships
www.nasdaq.com
IonQ Expands Strategic Partnerships to Drive Real-World Quantum Use
IonQ IONQ has recently expanded its strategic footprint through a series of high-impact partnerships spanning healthcare, logistics, and academic research, underscoring its ambition to drive real-world adoption of quantum computing.
#Iren #BitcoinMining #ArtificialIntelligence
www.nasdaq.com
This Is One of the Best Artificial Intelligence (AI) Stocks to Hold for the Next 10 Years
Shares of Iren (NASDAQ: IREN) more than tripled in 2025. The Bitcoin miner, founded in 2018, is pursuing a massive opportunity by offering its data centers for artificial intelligence (AI) cloud services.
#Neuroscience #Alzheimers #ClinicalTrials
www.nasdaq.com
NMRA Surges On Clinically Meaningful Results In Phase 1 Alzheimer's Disease Agitation Study
(RTTNews) - Neumora Therapeutics, Inc. (NMRA) has entered 2026 with momentum, announcing positive Phase 1b results for its lead candidate NMRA-511 in Alzheimer's disease agitation, along with a pipeline strategy that promises multiple clinical readouts across its neuroscience programs.
#NeumoraTherapeutics #Alzheimers #ClinicalTrials
www.nasdaq.com
Neumora Therapeutics Reports Encouraging Phase 1b Data For NMRA-511 In Alzheimer's Disease Agitation
(RTTNews) - Neumora Therapeutics, Inc. (NMRA) on Monday announced positive results from a Phase 1b study of NMRA-511 in patients with agitation associated with Alzheimer's disease (AD).
#MultipleSclerosis #FDAApproval #GenericDrugs
www.nasdaq.com
ScinoPharm Wins First FDA Approval With Glatiramer Acetate Injection For Multiple Sclerosis
(RTTNews) - ScinoPharm Taiwan (TWSE: 1789) today announced that the U. S. FDA has approved its Glatiramer Acetate Injection, a generic version of Teva's Copaxone, for the treatment of adult patients with multiple sclerosis.
#biopharmaceuticals #cancerresearch #clinicaltrials
www.nasdaq.com
HUTCHMED Begins Phase 3 Part Of Phase 2/3 Surufatinib-Camrelizumab Combo Study In Pancreatic Cancer
(RTTNews) - HUTCHMED (China) Ltd (HCM, HCM. L,0013. HK), a commercial-stage, biopharmaceutical company, announced on Monday that it has commenced the Phase III part of the Phase II/III trial to evaluate the efficacy of the combination of surufatinib combined with camrelizumab, nab-paclitaxel and gemcitabine as a first-line treatment for patients with metastatic pancreatic ductal adenocarcinoma or PDAC in China.
#HawaiianAirlines #TravelInnovation #Sustainability
www.nasdaq.com
Hawaiian Airlines Unveils $600 Mln Plan To Upgrade Service And Support Sustainability
(RTTNews) - Hawaiian Airlines, a unit of Alaska Air Group Inc. (ALK) on Monday unveiled a more than $600 million, five-year investment plan to improve the guest experience across Hawai'i through airport upgrades, technology enhancements and aircraft interior retrofits, while expanding community and sustainability initiatives.
#ArtificialIntelligence #DrugDiscovery #Oncology
www.nasdaq.com
InSilico Signs US$888Mln Multi-Year Oncology Drug Discovery Deal With Servier
(RTTNews) - InSilico Medicine Cayman TopCo. (3696. HK), an artificial intelligence-driven drug discovery company, has announced a multi-year research and development collaboration valued at up to $888 million with France-based Servier for drug discovery and development in oncology.
